Baxalta to Host Third Quarter 2015 Financial Results Conference Call

BANNOCKBURN, Ill.--(BUSINESS WIRE)-- Baxalta Incorporated (NYSE: BXLT) will announce its third quarter 2015 financial results on Thursday, Oct. 29, 2015, before the market opens.

Following the release of the company’s financial results, Baxalta will host a conference call with management beginning at 7:30 a.m. Central Time. To access the call, please dial 855-213-3946 (domestic) or 347-983-2217 (international). The conference ID is 52018017.

This call will also be webcast and accessible from the Baxalta website at investor.baxalta.com. The conference call will be recorded by Baxalta and is copyrighted material. It cannot be recorded or rebroadcast without Baxalta’s permission.

About Baxalta

Baxalta Incorporated (NYSE: BXLT) is a $6 billion global biopharmaceutical leader developing, manufacturing and commercializing therapies for orphan diseases and underserved conditions in hematology, oncology and immunology. Driven by passion to make a meaningful impact on patients’ lives, Baxalta’s broad and diverse pipeline includes biologics with novel mechanisms and advanced technology platforms such as gene therapy. The Baxalta Global Innovation and R&D Center is located in Cambridge, Massachusetts. Launched in 2015 following separation from Baxter International, Baxalta’s heritage in biopharmaceuticals spans decades. Baxalta’s therapies are available in more than 100 countries and it has advanced biological manufacturing operations across 12 facilities, including state-of-the-art recombinant production and plasma fractionation. Headquartered in Northern Illinois, Baxalta employs 16,000 employees worldwide.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151001006866/en/

Baxalta Media Relations
Geoffrey Mogilner, +1-224-940-8619
[email protected]
or
Baxalta Investor Relations
Mary Kay Ladone, +1-224-948-3371
[email protected]
or
Lorna Williams, +1-224-948-3511
[email protected]

Source: Baxalta Incorporated

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• This Is The Top REIT Stock Stifel Analysts Are Backing Right Now
• Moody’s upgrades Cushman & Wakefield rating to Ba3 on debt reduction